Gland Pharma shares zoom 13% despite 16% YoY drop in Q2 profit; here's why

Gland Pharma Q2 FY25: The generic injectable-focused company's consolidated net profit declined to Rs 163.5 crore in Q2 FY25 from Rs 194 crore in the year-ago period. Consolidated revenue, however, increased 2 per cent year-on-year (YoY) to Rs 1,405.8 crore.
Read The Rest at :